Cargando…
PSAT296 Graves’ Disease and Hurthle Cell Carcinoma: A Rare Presentation
INTRODUCTION: Hurthle cell carcinoma is a rare thyroid malignancy, only accounting for 3-5% of all thyroid malignancies. Thyroid tumors are classified as Hurthle cell carcinomas when they contain more than 75% Hurthle cells. Hurthle cells are oncocytic cells with an acidic cytoplasm and can contain...
Autores principales: | Bhatt, Plukshi J, Madhavan, Parvathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625052/ http://dx.doi.org/10.1210/jendso/bvac150.1691 |
Ejemplares similares
-
SUN-562 Hurthle Cell Carcinoma Presenting as Hyperfunctioning Nodule
por: Aviles, Ednalyn, et al.
Publicado: (2019) -
PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022) -
PSAT340 Thymic Hyperplasia in Graves’ Disease: A Case Report
por: Gordon, Ashley, et al.
Publicado: (2022) -
PSAT347 New Onset of Graves’ Disease after COVID-19 Vaccination
por: Anto Antony, Mc, et al.
Publicado: (2022) -
PSAT380 Characteristics and prognosis of Differentiated Thyroid Cancer in patients with Graves Disease
por: Panthi, Sujata, et al.
Publicado: (2022)